Literature DB >> 8727434

Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines.

T Lherm1, G Troché, M Rossignol, P Bordes, J F Zazzo.   

Abstract

OBJECTIVE: To evaluate the renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines.
DESIGN: Prospective, clinical study using sequential periods.
SETTING: A 12-bed surgical intensive care unit in a university hospital. PATIENTS: 14 patients with sepsis syndrome and 15 patients with septic shock treated with exogenous catecholamines were studied. They had no diuretic treatment. INTERVENTION: Two periods of 2 h each with and without 2 micrograms.kg-1.min-1 of dopamine infusion. Hemodynamic and renal data were obtained at the end of each period. Measurements were repeated after 48 h of dopamine infusion in patients with sepsis syndrome. All data were evaluated by the Wilcoxon rank test. MEASUREMENTS AND
RESULTS: In patients with sepsis syndrome, diuresis and creatinine clearance increased significantly by 100% and 60%, respectively, during low-dose dopamine infusion without any change in systemic hemodynamics. The renal response to dopamine decreased significantly after 48 h of dopamine infusion (P < 0.01). In patients with septic shock treated with catecholamines, no variation of either systemic hemodynamics or renal function was noted during low-dose dopamine infusion.
CONCLUSION: The renal effects of low-dose dopamine in patients with sepsis syndrome decrease with time. No renal effect of low-dose dopamine was observed in patients with septic shock treated with catecholamines. These findings suggest a desensitization of renal dopaminergic receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8727434     DOI: 10.1007/BF01712239

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  31 in total

1.  EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW.

Authors:  R H MCDONALD; L I GOLDBERG; J L MCNAY; E P TUTTLE
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

2.  Haemodynamic effects of dopamine in septic shock.

Authors:  B Regnier; M Rapin; G Gory; F Lemaire; B Teisseire; A Harari
Journal:  Intensive Care Med       Date:  1977-08       Impact factor: 17.440

3.  Two-hour versus 22-hour creatinine clearance in critically ill patients.

Authors:  R N Sladen; E Endo; T Harrison
Journal:  Anesthesiology       Date:  1987-12       Impact factor: 7.892

4.  The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.

Authors:  M Waelbroeck; G Taton; M Delhaye; P Chatelain; J C Camus; R Pochet; J L Leclerc; J M De Smet; P Robberecht; J Christophe
Journal:  Mol Pharmacol       Date:  1983-09       Impact factor: 4.436

Review 5.  Adrenoceptors as models for G protein-coupled receptors: structure, function and regulation.

Authors:  D A Schwinn
Journal:  Br J Anaesth       Date:  1993-07       Impact factor: 9.166

6.  Subsensitization of beta-adrenoceptors in airways and lymphocytes of healthy and asthmatic subjects.

Authors:  D P Tashkin; M E Conolly; R I Deutsch; K K Hui; M Littner; P Scarpace; I Abrass
Journal:  Am Rev Respir Dis       Date:  1982-02

7.  Prognosis in acute organ-system failure.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Ann Surg       Date:  1985-12       Impact factor: 12.969

8.  Steady-state pharmacokinetics of dopamine in adult patients.

Authors:  P Le Corre; Y Malledant; M Tanguy; R Le Verge
Journal:  Crit Care Med       Date:  1993-11       Impact factor: 7.598

9.  Low-dose dopamine preserves renal blood flow in endotoxin shocked dogs treated with ibuprofen.

Authors:  M P Fink; R Nelson; R Roethel
Journal:  J Surg Res       Date:  1985-06       Impact factor: 2.192

10.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

View more
  5 in total

Review 1.  "Renal dose" dopamine in surgical patients: dogma or science?

Authors:  P W Perdue; J R Balser; P A Lipsett; M J Breslow
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

Review 2.  An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure.

Authors:  M K Dishart; J A Kellum
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

3.  Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.

Authors:  Christian Radke; Dagmar Horn; Christian Lanckohr; Björn Ellger; Michaela Meyer; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-07       Impact factor: 6.447

4.  The effects of low-dose dopamine infusions on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline.

Authors:  R N Juste; K Panikkar; N Soni
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

5.  The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence.

Authors: 
Journal:  Crit Care       Date:  1997       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.